Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It has gained research attention for its dual-action potential in blood sugar regulation and weight management, making it a candidate for in-vitro studies focused on metabolic pathways.
$130.00 – $175.00
Free Shipping on orders over $99
Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.
Molecular Formula: C225H348N48O68
Molecular Weight: 4813.56 g/mol
Tirzepatide’s unique action on both GIP and GLP-1 receptors provides insights into pathways related to glucose metabolism and insulin sensitivity in laboratory settings.
Tirzepatide is intended solely for laboratory research and is not for human consumption. Any patented status of Tirzepatide must be respected by researchers.
“Tirzepatide is a patented compound developed by Eli Lilly and marketed under the brand name Mounjaro®. Any reference to tirzepatide is solely for informational and educational purposes regarding its availability for laboratory research only. This product is not manufactured, endorsed, or approved by Eli Lilly.”
Frias, J.P., et al. “Dual GIP and GLP-1 Agonists for Metabolic Regulation” (New England Journal of Medicine, 2021).
Lorem ipsum dolor sit amet, consectetur adipiscing elit
All peptides sold by Peptide Pros are for research purposes only and are not intended for human or veterinary use. Please ensure compliance with local regulations before ordering.
